ANTISENSE PEPTIDE

Antisense peptides are used as potential ligands for protein-protein interactions studies. The methods detailed on this website have been developed to allow in silico identification of novel protein-protein interactions to be carried out using freely available software. The technology described is based on the idea that proteins coded by the sense and antisense strands of DNA interact. The attached Protocol has specifically been written by Dr Nat Milton of Leeds Beckett University, who has used the techniques in both research and commercial settings. The methods are aimed at undergraduate and postgraduate students plus academic staff for use in non-commercial activities. The main method is based around antisense peptide screening [1] and has been adapted to protein sequence database screening [2].

ASDiagram


The protocol details how to use an online method (using a
Python script or Word version which can be used in an online Python Compiler or a downloaded version of Python 3) to generate antisense peptide sequences from a target protein mRNA sequence and has been based on the methods outlined in [2],[3],[4]. Methods using the antisense peptides in BLAST searches to identify potential protein interactions with the target protein are included. Simple methods for 3D modelling and analysis to predict the structure of complexes between the proteins identified from the antisense peptide screening can also be used. A 3D modelling method using the ZDOCK server to predict protein-protein interactions from protein structure files for two interacting proteins identified using antisense peptide BLAST searches [5],[6] has been detailed in the attached protocol. The interacting sequences identified from the BLAST searches are used as potential contact residues to direct the predictions in this method.

Support for these Bioinformatics methods is available via the Email or Skype links on the
Support page.

An example of the use of these techniques was a study to identify Alzheimer's amyloid-ß (Aß) binding peptides that could block both neurotoxicity and fibril formation of Aß. The binding peptides were developed based on generating antisense peptides using the messenger RNA (mRNA) sequence for the Aß 1-43 peptide as a template
[3],[4] that would specifically bind the Aß 1-43 peptide. The Aß antisense peptide sequences and data from their generation plus characterisation were the subject of published patent applications [4]. Subsequent studies by other groups demonstrated that similar Aß antisense peptides were able to prevent the toxicity of Aß [7], confirming the original observations.